Market closed
IDEXX Laboratories/$IDXX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About IDEXX Laboratories
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Ticker
$IDXX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
11,000
Website
IDXX Metrics
BasicAdvanced
$34B
40.48
$10.36
1.33
-
Price and volume
Market cap
$34B
Beta
1.33
52-week high
$583.39
52-week low
$398.50
Average daily volume
561K
Financial strength
Current ratio
1.421
Quick ratio
0.812
Long term debt to equity
32.431
Total debt to equity
54.009
Interest coverage (TTM)
33.56%
Management effectiveness
Return on assets (TTM)
22.79%
Return on equity (TTM)
59.42%
Valuation
Price to earnings (TTM)
40.476
Price to revenue (TTM)
9.027
Price to book
21.26
Price to tangible book (TTM)
21.26
Price to free cash flow (TTM)
43.787
Growth
Revenue change (TTM)
7.16%
Earnings per share change (TTM)
5.57%
3-year revenue growth (CAGR)
7.04%
3-year earnings per share growth (CAGR)
5.91%
What the Analysts think about IDXX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for IDEXX Laboratories stock.
IDXX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
IDXX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
IDXX News
AllArticlesVideos
IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
Business Wire·5 days ago
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
GlobeNewsWire·1 month ago
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for IDEXX Laboratories stock?
IDEXX Laboratories (IDXX) has a market cap of $34B as of January 22, 2025.
What is the P/E ratio for IDEXX Laboratories stock?
The price to earnings (P/E) ratio for IDEXX Laboratories (IDXX) stock is 40.48 as of January 22, 2025.
Does IDEXX Laboratories stock pay dividends?
No, IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders as of January 22, 2025.
When is the next IDEXX Laboratories dividend payment date?
IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders.
What is the beta indicator for IDEXX Laboratories?
IDEXX Laboratories (IDXX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.